Quan Hude, Galbraith P Diane, Norris Colleen M, Southern Danielle A, King Kathryn, Verhoef Marja J, Knudtson Marril L, Ghali William A
Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Can J Cardiol. 2007 Jun;23(8):635-40. doi: 10.1016/s0828-282x(07)70225-8.
Chelation therapy is frequently used by patients for the treatment of coronary artery disease. However, relatively little is known about patient attitudes and beliefs that underlie the use of this treatment. The aim of the present study was to document patients' opinions and beliefs about health care decision making, physician and patient communication and relationships, and reasons for using or not using chelation therapy as treatment for coronary artery disease.
A mail survey was sent to patients who underwent coronary angiography between 1998 and 2000 in Alberta. Information was collected on self-reported reasons for chelation therapy use, sociodemographic characteristics, communication and relationships between patients and physicians, as well as beliefs regarding surgery, medications and chelation therapy.
Of the 780 patients who received surveys, 96 users and 264 nonusers of chelation therapy completed questionnaires. Among the users, 20.8% believed that chelation therapy could cure heart disease, 44.2% believed that it could relieve symptoms, 16.7% believed that it could have side effects and 58.4% believed that it could increase quality of life. Users and nonusers were similar in their beliefs about safety and benefits of heart surgery, but users of chelation therapy were less likely than nonusers to believe that using conventional medications could prevent worsening of heart disease (53.1% versus 67.4%), increase quality of life (74.0% versus 85.2%) and give a feeling of control over heart disease (61.5% versus 77.7%).
Many chelation therapy users appeared to have negative views toward the benefits of conventional medications and positive views toward the safety of chelation therapy. Users and nonusers of chelation therapy had the same views toward the benefits and safety of heart surgery.
螯合疗法常被患者用于治疗冠状动脉疾病。然而,对于这种治疗方法背后患者的态度和信念,我们了解得相对较少。本研究的目的是记录患者对于医疗决策、医患沟通与关系,以及使用或不使用螯合疗法治疗冠状动脉疾病的原因的看法和信念。
向1998年至2000年在艾伯塔省接受冠状动脉造影的患者发送邮件调查问卷。收集了关于自我报告的使用螯合疗法的原因、社会人口统计学特征、患者与医生之间的沟通与关系,以及对手术、药物和螯合疗法的信念等信息。
在收到调查问卷的780名患者中,96名螯合疗法使用者和264名非使用者完成了问卷。在使用者中,20.8%的人认为螯合疗法可以治愈心脏病,44.2%的人认为可以缓解症状,16.7%的人认为会有副作用,58.4%的人认为可以提高生活质量。使用者和非使用者对心脏手术的安全性和益处的信念相似,但螯合疗法使用者比非使用者更不相信使用传统药物可以预防心脏病恶化(53.1%对67.4%)、提高生活质量(74.0%对85.2%)以及给予对心脏病的控制感(61.5%对77.7%)。
许多螯合疗法使用者似乎对传统药物的益处持负面看法,而对螯合疗法的安全性持正面看法。螯合疗法使用者和非使用者对心脏手术的益处和安全性看法相同。